Join Our Members List For Exclusive Reports

    June 19, 2013

    Financial engineering failed dramatically in the financial crisis, but maybe it could be used to help persuade institutions to invest in cancer research.

    Professor Andrew Lo of MIT’s Sloan School of Management explains the long view with columnist John Authers.

    Lo says, “We have, literally tens of thousands of scientists that have many ideas and
    are starved for resources. If we can get the funding that they need, we think
    they can make breakthroughs in cancer in as little as 5 to 10 years from now,” to which Authers adds some thoughts and concludes,”It’s a very pleasant change to start to think of financial engineering as a possible cause for good – but really, why not?”

    For more video content from the Financial Times, visit

    Contributed by


    You Might Like

    Alexandra Bruce

    View all posts

    Add comment

    Most Viewed Posts